The secondary fungal metabolite gliotoxin targets proteolytic activities of the proteasome

Chemistry and Biology

Volumn 6, Issue 10, 1999, Pages 689-698

  Kroll, Mathias ^a   Arenzana Seisdedos, Fernando ^a   Bachelerie, Françoise ^a   Thomas, Dominique ^a   Friguet, Bertrand ^b   Conconi, Mariangela ^b  

^a INSTITUT PASTEUR   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Gliotoxin; Inhibition; I B ; NF B; Proteasome

Indexed keywords

EID: 0033214494     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(00)80016-2     Document Type: Article

References (65)

1. 1. Burch, P.A., Karp, J.E., Merz, W.G., Kuhlman, J.E. & Fishman, E.K. (1987). Favorable outcome of invasive aspergillosis in patients with acute leukemia. J. Clin. Oncol. 5, 1985-1993.
2. 2. Sutton, P., Newcombe, W.R., Waring, P. & Müllbacher, A. (1994). Investigation of the potential use of immunosuppressive agent gliotoxin in organ transplantation. Infect. Immunol. 62, 1192-1198.
3. 3. Waring, P., Eichner, R.D. & Müllbacher, A. (1988).). The chemistry and biology of the immunomodulating agent gliotoxin and related epipolythiodioxopiperazines. Med. Res. Rev. 8, 499-524.
4. 4. Müllbacher, A. & Eichner, R.D. (1984). Immunosuppression in vitro by a metabolite of a human pathogenic fungus. Proc. Natl Acad. Sci. USA 81, 3835-3837.
5. 5. Müllbacher, A., Waring, P., Palni, T. & Eichner, R.D. (1986). Structural relationship of epipolythiodioxopiperazines and their immunomodulating activity. Mol. Immunol. 23, 231-235.
6. 6. Waring, P., Eichner, R.D., Müllbacher, A. & Sjaarda, A. (1988). Gliotoxin induces apoptosis in macrophages unrelated to its antiphagocytic properties. J. Biol. Chem. 263, 18493-18499.
7. 7. Jordan, T.W. & Cordiner, S.T. (1987). Fungal epipolythiodioxopiperazine toxins have therapeutic potential and roles in disease. Trends Plant Sci. 8, 144-149.
8. 8. Okamoto, M., Yoshuda, K., Uchida, I., Nishikawa, M., Kohsaka, M. & Aoki, H. (1986). Studies of platelet activating factor (PAF) antagonists from microbial products. I. Bisdethiobis(methylthio)gliotoxin and its derivatives. Chem. Pharm. Bull. 34, 340-344.
9. 9. Cordiner, S.J. & Jordan, T.W. (1983). Fungal epipolythiodioxopiperazine toxins have therapeutic potential and roles in disease. Biochem. J. 212, 197-204.
10. 10. Jordan, T.W. & Pedersen, J.S. (1986). Sporidesmin and gliotoxin induce cell detachment and perturb microfilament structure in cultured liver cells. J. Cell. Sci. 85, 33-46.
11. 11. Pahl, H.L., et al., & Baeuerle, P.A. (1996). The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-kappaB. J. Exp. Med. 183, 1829-1840.
12. 12. Palombella, V., Rando, O., Goldberg, A. & Maniatis, T. (1994). The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell 78, 773-785.
13. 13. Traenckner, E.B.M., Wilk, S. & Baeuerle, P.A. (1994). A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa B. EMBO J. 13, 5433-5441.
14. 14. Mellits, K., Hay, R. & Goodbourn, S. (1993). Proteolytic degradation of MAD3 (I kappa B alpha) and enhanced processing of the NF-kappa B precursor p105 are obligatory steps in the activation of NF-kappa B. Nucleic Acids Res. 21, 5059-5066.
15. 15. Traenckner, E.B.M., Pahl, H.L., Henkel, T., Schmidt, K.N., Wilk, S. & Baeuerle, P.A. (1995). Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli. EMBO J. 14, 2876-2883.
16. 16. Brown, K., Gerstberger, S., Carlson, L., Franzoso, G. & Siebenlist, U. (1995). Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation. Science 267, 1485-1488.
17. 17. Brockman, J.A., et al., & Ballard, D.W. (1995). Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation. Mol. Cell. Biol. 15, 2809-2818.
18. 18. DiDonato, J.A., et al., & Karin, M. (1996).). Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation. Mol. Cell. Biol. 16, 1295-1304.
19. 19. Scherer, D., Brockman, J., Chen, Z., Maniatis, T. & Ballard, D. (1995). Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination. Proc. Natl Acad. Sci. USA 92, 11259-11263.
20. 20. Rodriguez, M.S., et al., & Arenzana-Seisdedos, F. (1996). Identification of lysine residues required for signal-induced ubiquitination and degradation of I kappa B-alpha in vivo. Oncogens 12, 2425-2435.
21. 21. Baldi, L., Brown, K., Franzoso, G. & Siebenlist, U. (1996). Critical role for lysines 21 and 22 in signal-induced, ubiquitin-mediated proteolysis of I kappa B-alpha. J. Biol. Chem. 5, 376-379.
22. 22. Gonen, H., et al., & Ciechanover, A. (1999). Identification of the ubiquitin carrier proteins, E2s, involved in signal-induced conjugation and subsequent degradation of IkappaBalpha. J. Biol. Chem. 274, 14823-14830.
23. 23. Krek, W. (1998). Proteolysis and the G1-S transition: the SCF connection. Curr. Opin. Gen. Dev. 8, 36-42.
24. 24. Yaron, A., et al., & Ben-Neriah, Y. (1998).). Identification of the receptor component of the IκBα-ubiquitin ligase. Nature 396, 590-594.
25. 25. Winston, J.T., Strack, P., Beer-Romero, P., Chu, C.Y., Elledge, S.J. & Harper, J.W. (1999). The SCF(βTrCP)-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IκBα and β-catenin and stimulates IκBα ubiquitination in vitro. Genes Dev. 13, 270-283.
26. 26. Spencer, E., Jiang, J. & Chen, Z.J. (1999). Signal-induced ubiquitination of IκBα by the F-box protein Slimb/β-TrCP. Genes Dev. 13, 284-294.
27. 27. Kroll, M., et al., & Benarous, R. (1999). Inducible degradation of IκBα by the proteasome requires interaction with the F-box protein h-βTrCP. J. Biol. Chem. 274, 7941-7945.
28. 28. Coux, O., Tanaka, K. & Goldberg, A.L. (1996). Structure and functions of the 20S and 26S proteasomes. Annu. Rev. Biochem. 65, 801-847.
29. 29. Tanaka, K., Li, K., Ichihara, A., Waxman, L. and Goldberg, A.L. (1986). A high molecular weight protease in the cytosol of rat liver. I. Purification, enzymological properties, and tissue distribution. J. Biol. Chem. 261, 15197-15202.
30. 30. Reits, A.J.E., Benham, M.A., Plougastel, B., Neefjes, J. & Trowsdale, J. (1997). Dynamics of proteasome distribution in living cells. EMBO J. 15, 6087-6094.
31. 31. Rivett, J. (1993). Proteasomes: multicatalytic proteinase complexes. Biochem. J. 291, 1-10.
32. 32. Baumeister, W., Dahlmann, B., Kopp, H.F., Kuehn, L. & Pfeifer, G. (1988). Electron microscopy and image analysis of the multicatalytic proteinase. FEBS Lett. 241, 239-245.
33. 33. Dick, T.P., et al., & Schild, H. (1998). Contribution of proteasomal subunits to the cleavage of peptide substrates analyzed with yeast mutants. J. Biol. Chem. 273, 25637-25646.
34. 34. Groll, M., et al., & Huber, R. (1997). Structure of 20S proteasome from yeast at 2.4 Å resolution. Nature 386, 463-471.
35. 35. Orlowski, M., Cardozo, C. & Michaud, C. (1993). Evidence for the presence of five distinct proteolytic components in the pituitary multicatalytic proteinase complex. Properties of two components cleaving bonds on the carboxyl side of branched chain and small neutral amino acids. Biochemistry 32, 1563-1572.
36. 36. Kroll, M., et al., & Rodriguez, M.S. (1997). The carboxy-terminus of IκBα determines susceptibility to degradation by the catalytic core of the proteasome. Oncogene 15, 1841-1850.
37. 37. Maki, C.G., Huibregtse, J.M. & Howley, P.M. (1996). In vivo ubiquitination and proteasome-mediated degradation of p53. Cancer Res. 56, 2649-2654.
38. 38. Aberle, H., Bauer, A., Stappert, J., Kispert, A. & Kemler, R. (1997). β-catenin is a target for the ubiquitin-proteasome pathway. EMBO J. 16, 3797-3804.
39. 39. Johnston, J.A., Johnson, E.S., Waller, P.R. & Varshavsky, A. (1995). Methotrexate inhibits proteolysis of dihydrofolate reductase by the N-end rule pathway. J. Biol. Chem. 270, 8172-8178.
40. 40. Murakami, Y., Tanahashi, N., Tanaka, K., Omura, S. & Hayashi, S. (1996). Proteasome pathway operates for the degradation of ornithine decarboxylase in intact cells. Biochem. J. 317, 77-80.
41. 41. Li, H., Marshall, Z.M. & Whorton, A.R. (1999). Stimulation of cystine uptake by nitric oxide: regulation of endothelial cell glutathione levels. Am. J. Physiol. 276, C803-C811.
42. 42. Gregori, L., Fuchs, C., Figueiredo-Pereira, M.E., Van Nostrand, W.E. & Goldgaber, D. (1995). Amyloid β-protein inhibits ubiquitin-dependent protein degradation in vitro. J. Biol. Chem. 270, 19702-19708.
43. 43. Figueiredo-Pereira, M.E., Chen, W.E., Li, J. & Johdo, O. (1996). The antitumor drug aclacinomycin A, which inhibits the degradation of ubiquitinated proteins, shows selectivity for the chymotrypsin-like activity of the bovine pituitary 20 S proteasome. J. Biol. Chem. 271, 16455-16459.
44. 44. Meyer, S., Gail Kohler, N. & Joly, A. (1997). Cyclosporine A is an uncompetitive inhibitor of proteasome activity and prevents NF-kappaB activation. FEBS Lett. 413, 354-358.
45. 45. Gazos Lopes, U., Erhardt, P., Yao, R. & Cooper, G.M. (1997). p53-dependent induction of apoptosis by proteasome inhibitors. J. Biol. Chem. 272, 12893-12896.
46. 46. Wójcik, C., et al., & Jakóbisiak, M. (1997). Apoptosis induced in L1210 leukemia cells by an inhibitor of the chymotrypsin-like activity of the proteasome. Apoptosis 2, 455-462.
47. 47. Waring, P. (1990). DNA fragmentation induced in macrophages by gliotoxin does not require protein synthesis and is preceded by raised inositol triphosphate levels. J. Biol. Chem. 265, 14476-14480.
48. 2+ salts. Int. J. Immunopharmacol. 12, 445-457.
49. 49. Piva, T.J. (1994). Gliotoxin induces apoptosis in mouse L929 fibroblast cells. Biochem. Mol. Biol. Int. 33, 411-419.
50. 50. Waring, P., Khan, T. & Sjaarda, A. (1997). Apoptosis induced by gliotoxin is preceded by phosphorylation of Histone H3. J. Biol. Chem. 272, 17929-17936.
51. 51. Beg, A.A. & Baltimore, D. (1996). An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 274, 782-784.
52. 52. Wang, C.Y., Mayo, M.W. & Baldwin, A.S., Jr (1996). TNF-and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science 274, 784-786.
53. 53. Van Antwerp, D.J., Martin, S.J., Kafri, T., Green, D.R. & Verma, I.M. (1996). Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science 274, 787-789.
54. 54. Wang, C.Y., Mayo, M.W., Korneluk, R.G., Goeddel, D.V. & Baldwin A.S., Jr, (1998). NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281, 1680-1683.
55. 55. Chu, Z.-L., McKinsey, T.A., Liu, L., Gentry, J.J., Malim, M.H. & Ballard, D.W. (1997). Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control. Proc. Natl Acad. Sci. USA 94, 10057-10062.
56. 56. Wu, M.X., Ao, Z., Prasad, K.V.S., Wu, R. & Schlossman, S. (1998). IEX-1L, an apoptosis inhibitor involved in NF-κB-mediated cell survival. Science 281, 998-1001.
57. 57. Heinemeyer, W., Kleinschmidt, J., Saidowsky, C.E. & Wolf, D.H. (1991). Proteinase yscE, the yeast proteasome/multicatalytic-multifunctional proteinase: mutants unravel its function in stress induced proteolysis and uncover its necessity for cell survival. EMBO J. 10, 555-562.
58. 58. Heinemeyer, W., Gruhler, A., Mohrle, V., Mahe, Y. & Wolf, D. H. (1993). PRE2, highly homologous to the human major histocompatibility complex-linked RING10 gene, codes for a yeast proteasome subunit necessary for chrymotryptic activity and degradation of ubiquitinated proteins. J. Biol. Chem. 268, 5115-5120.
59. 59. Uehara, T., et. al., & Nomura, Y. (1999). Transient nuclear factor B (NF-B) activation stimulated by interleukin-1 may be partly dependent on proteasome activity, but not phosphorylation and ubiquitination of the IB molecule, in C6 glioma cells. J. Biol. Chem. 274, 15875-15882.
60. 60. Fehrentz, J.A., Heitz, A. & Castro, B. (1985). Synthesis of aldehydic peptides inhibiting renin. Int. J. Pept. Protein Res. 26, 236-241.
61. 61. Arenzana-Seisdedos, F., Thomson, J.A., Rodriguez, M.S., Bachelerie, F., Thomas, D. & Hay, R.T. (1995). Inducible nuclear expression of newly synthesized I kappa B alpha negatively regulates DNA-binding and transcriptional activities of NF-kappa B. Mol. Cell. Biol. 15, 2689-2696.
62. 62. Sutton, P., Moreland, A., Hutchinson, I.V. & Müllbacher, A. (1995). Investigation of the potential use of immunosuppressive agent gliotoxin in organ transplantation. Transplantation 60, 900-902.
63. 63. Jaffray, E., Wood, K. & Hay, R. (1995). Domain organization of I kappa B alpha and sites of interaction with NF-kappa B p65. Mol. Cell. Biol. 15, 2166-2172.
64. 64. Nixon, P.F. & Blakley, R.L. (1968). Dihydrofolate reductase of Streptococcus faicium. II. Purification and some properties of two dihydrofolate reductases from the amethopterin-resistant mutant Streptococcus faecium var. Durans strain A. J. Biol. Chem. 243, 4722-4731.
65. 65. Friguet, B., Szweda, L.I. & Stadtman, E.R. (1994). Susceptibility of glucose-6-phosphate dehydrogenase modified by 4-hydroxy-2-nonenal and metal-catalyzed oxidation to proteolysis by the multicatalytic protease. Arch. Biochem. Biophys. 311, 168-173.